Advanced Medical Technologies The USC Roski Eye Institute has pioneered the use of cutting-edge diagnostic tools such as ultra-high speed Fournier domain optical coherence tomography and developed the world’s first FDA-approved artificial retina, Argus II. These advancements indicate a strong focus on innovative medical technology, presenting opportunities for companies providing advanced ophthalmic equipment, diagnostic tools, and surgical solutions to collaborate or supply equipment.

Global and Regional Leadership Recognized consistently as one of the top ophthalmology programs nationally and with clinics in Los Angeles, Pasadena, and Arcadia, the institute has a broad patient base and influence. Partnerships with technology providers, medical device firms, or pharmaceutical companies could leverage this extensive regional and national presence for campaign expansion and product testing.

Research and Development Focus USC Roski’s leadership in epidemiological studies and breakthrough research in stem cell therapy and retinal disease presents potential for research collaborations, clinical trial partnerships, and sponsorship opportunities with organizations focused on biomedical innovation and ophthalmic treatments.

Community Engagement & Accessibility The institute’s initiatives like USC Street Medicine and collaborations with diverse organizations such as LoveOn4Paws and the TransLatina Coalition demonstrate strong community outreach and social responsibility. These connections open avenues for companies interested in social impact investments, community health solutions, and patient engagement platforms.

Recent Recognition & Growth The institute’s recent accolades, including being a Vizient Top Performer, highlight operational excellence and growth potential. This reputation can facilitate introductions and partnerships with healthcare technology providers, service organizations, and vendors aiming to work with high-performing medical institutions.